Latest Stereotactic surgery Stories
ATLANTA, Feb. 17, 2012 /PRNewswire/ -- The Fraxion(TM) head frame helps ensure accuracy and precision in stereotactic radiation therapy (SRT) of cancer targets in the brain and cranium. Elekta's Fraxion is the first to introduce an innovative system that integrates all proven cranial immobilization options in a single solution. "Building on more than 60 years of stereotaxy experience, Fraxion provides the accuracy and precision that clinicians need for even the most challenging...
SUNNYVALE, Calif., Feb. 15, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Citi 2012 Global Health Care Conference in New York City on Tuesday, February 28, 2012 at 11:00 a.m. EST/8:00 a.m. PST. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com. The webcast replay of...
ATLANTA, Feb. 13, 2012 /PRNewswire/ -- High-dose Stereotactic Body Radiation Therapy (SBRT) has emerged as a critical treatment option for patients with prostate, lung and liver cancer. The challenge has been delivering SBRT's large doses as quickly as possible, for improved patient comfort and to reduce the chance the patient will move during treatment delivery. While Volumetric Modulated Arc Therapy (VMAT) promises much faster treatment delivery, clinicians have been...
DUBAI, United Arab Emirates, Jan. 27, 2012 /PRNewswire/ - An estimated 72,000 healthcare professionals gathered at the Dubai World Trade Centre Jan. 23-26 for the 2012 Arab Health Congress and Exhibition. The meeting also provided the framework for the 2nd Multi-Disciplinary Approach to Cancer Therapy Conference. During the exhibition, Elekta demonstrated advanced solutions ranging from conventional radiation therapy with Elekta Compact(TM)* to stereotactic neurosurgery with...
SUNNYVALE, Calif., Jan. 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today publication of a study demonstrating the benefits of the CyberKnife® Robotic Radiosurgery System in treating central lung tumors. Historically, the treatment of central lung tumors using gantry based Stereotactic Body Radiotherapy (SBRT) has been challenging and required a great deal of accuracy to avoid risks of damaging critical...
BANGALORE, India, Jan. 18,( )2012 /PRNewswire/ -- Doctors at BGS Global Cancer Institute at BGS Global Hospitals in Bangalore have begun delivering advanced radiotherapy treatments using the first clinical TrueBeam(TM) STx medical linear accelerator in Asia. A 57-year-old female patient with a brain metastasis received whole brain radiotherapy and this will be followed by stereotactic radiosurgical boosts to the lesion using the fast and precise system. "The whole procedure, the...
SUNNYVALE, Calif., Jan. 17, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that CHRISTUS MUGUERZA Hospital Alta Especialidad in Monterrey, Mexico has starting treating patients with the CyberKnife® Robotic Radiosurgery System. CHRISTUS MUGUERZA is the first center in Mexico now offering patients the benefits of the CyberKnife System to treat tumors anywhere in the body. The CyberKnife System is a...
SUNNYVALE, Calif., Jan. 5, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Needham Growth Conference in New York City on Thursday, January 12, 2012 at 8:40 a.m. EST/5:40 a.m. PST. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at http://www.accuray.com. The webcast replay of the presentation...
SUNNYVALE, Calif., Dec. 22, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco on Monday, January 9, 2012 at 4:30 p.m. PST/7:30 p.m. EST. A live webcast of the presentations will be available online from the Investor Relations page of the Company's website at...
SUNNYVALE, Calif., Dec. 19, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that 23 leading medical centers globally have installed both a CyberKnife(®) Robotic Radiosurgery System and a TomoTherapy® System enabling the delivery of personalized treatment for the full spectrum of radiation oncology patients. These centers include smaller community sites in rural areas, mid-sized regional hospitals and large...
